AU2003281845A1 - Modulation of upa-mediated functions via the aminoterminal fragment of mannose-6-phosphate/insuline-like growth factor 2 receptor (cd222) - Google Patents
Modulation of upa-mediated functions via the aminoterminal fragment of mannose-6-phosphate/insuline-like growth factor 2 receptor (cd222)Info
- Publication number
- AU2003281845A1 AU2003281845A1 AU2003281845A AU2003281845A AU2003281845A1 AU 2003281845 A1 AU2003281845 A1 AU 2003281845A1 AU 2003281845 A AU2003281845 A AU 2003281845A AU 2003281845 A AU2003281845 A AU 2003281845A AU 2003281845 A1 AU2003281845 A1 AU 2003281845A1
- Authority
- AU
- Australia
- Prior art keywords
- insuline
- upa
- mannose
- receptor
- modulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT11932002A AT413031B (de) | 2002-08-06 | 2002-08-06 | Verwendung von cd222 oder eines abgeleiteten peptids zur hemmung von fibrinolyse, zelladhäsion und zellmigration in vitro |
ATA1193/2002 | 2002-08-06 | ||
PCT/AT2003/000224 WO2004013177A1 (de) | 2002-08-06 | 2003-08-05 | MODULATION uPA-VERMITTELTER FUNKTIONEN DURCH DAS AMINOTERMINALE FRAGMENT DES MANNOSE-6-PHOSPHAT/INSULINÄHNLICHEN WACHSTUMSFAKTOR 2 REZEPTORS (CD222) |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003281845A1 true AU2003281845A1 (en) | 2004-02-23 |
Family
ID=31192778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003281845A Abandoned AU2003281845A1 (en) | 2002-08-06 | 2003-08-05 | Modulation of upa-mediated functions via the aminoterminal fragment of mannose-6-phosphate/insuline-like growth factor 2 receptor (cd222) |
Country Status (3)
Country | Link |
---|---|
AT (1) | AT413031B (de) |
AU (1) | AU2003281845A1 (de) |
WO (1) | WO2004013177A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010146059A2 (en) | 2009-06-16 | 2010-12-23 | F. Hoffmann-La Roche Ag | Biomarkers for igf-1r inhibitor therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5679350A (en) * | 1992-05-28 | 1997-10-21 | The University Of Toledo | Method of delivery of a medicament to a cancer cell using a pathway of plasminogen activator material |
DE69921102T2 (de) * | 1998-03-05 | 2006-02-02 | Chiron Corp., Emeryville | Verfahren zur verbesserung der serum-halbwertszeit von biologisch aktiven molekülen |
-
2002
- 2002-08-06 AT AT11932002A patent/AT413031B/de not_active IP Right Cessation
-
2003
- 2003-08-05 AU AU2003281845A patent/AU2003281845A1/en not_active Abandoned
- 2003-08-05 WO PCT/AT2003/000224 patent/WO2004013177A1/de not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AT413031B (de) | 2005-10-15 |
ATA11932002A (de) | 2005-03-15 |
WO2004013177A1 (de) | 2004-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7109500A (en) | Liquefracture handpiece | |
AU7373100A (en) | Liquefracture handpiece | |
AU2317699A (en) | Dental restoratives | |
AU7496800A (en) | Liquefracture handpiece | |
AU2002252156A1 (en) | Implantable device using ultra-nanocrystalline diamond | |
AU7059300A (en) | Immediate provisional implant | |
AUPP812199A0 (en) | Headgear | |
AU2171500A (en) | Ambulatory apnea screening device | |
AU1820401A (en) | Dental crown | |
AU3120900A (en) | Lingualize occlusal bur | |
IL159058A0 (en) | 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators | |
AU4425399A (en) | Novel therapeutic agents that modulate 5-ht receptors | |
AU5570899A (en) | Purified human papillomavirus | |
AU1601701A (en) | Methods for generating single stranded cdna fragments | |
AU2002245258A1 (en) | Modulating insulin receptor signaling | |
AU2003281845A1 (en) | Modulation of upa-mediated functions via the aminoterminal fragment of mannose-6-phosphate/insuline-like growth factor 2 receptor (cd222) | |
AU5022400A (en) | Tumor necrosis factor receptor 5 | |
AU2002334940A1 (en) | Risk management clearinghouse | |
AU2713399A (en) | 5-heteroaryl substituted indoles | |
AU3628800A (en) | Human tumor necrosis factor receptor tr9 | |
AU2003257651A1 (en) | 4'-thionucleotide | |
AUPQ210199A0 (en) | Improved dental crown | |
AU2965199A (en) | Medicine mini-chest | |
AU5379200A (en) | Bone stimulating factor | |
AU2003273926A1 (en) | Isomerisation of chiral homogeneous o,o'-dihydroxybiphenyl derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |